NATIONAL BREAST CANCER AWARENESS MONTH

The Board of Sponsors of National Breast Cancer Awareness Month is dedicated to increasing awareness of breast cancer issues, especially the importance of early detection of breast cancer.

This message is communicated through a nationwide educational campaign to audiences including women in all age and ethnic groups, the general public, state and federal governments, women's health care professionals, and employers.

During 2002 an estimated 203,500 new cases of breast cancer are expected to occur among women in the United States. NBCAM encourages all women to recognize the importance of early breast cancer detection by participating in National Mammography Day on October 18, 2002.

If you would like additional information about National Breast Cancer Awareness Month, click here.

This announcement appears on the NATIONAL BREAST CANCER AWARENESS MONTH (NBCAM) website, 2002 Copyright of AstraZeneca HealthCare Foundation. (Posted 10/04/02)

UF PATHOLOGIST RECEIVES AMERICAN CANCER SOCIETY GRANT

The American Cancer Society has awarded University of Florida pathologist Kenneth A. Iczkowski, M.D., a three-year, $183,000 Research Scholar Grant to study molecular changes on the surface of prostate cancer cells that could someday help scientists predict a patient's prognosis.

Iczkowski also recently received a Veterans Affairs Merit Review grant amounting to more than $26,000 to pursue this same line of investigation. Iczkowski holds a dual appointment as an assistant professor of pathology, immunology and laboratory medicine at UF's College of Medicine and as a pathologist at Gainesville's Malcom Randall Veterans Affairs Medical Center.

This article was featured in the September 10, 2002 issue of the Health Science Center News (by Melanie Fridl Ross). For the full version Click here. (Posted 10/04/02)

UF'S ROSENBLOOM RECOGNIZED AS DISTINGUISHED ENDOCRINOLOGIST

The Endocrine Society has selected Arlan Rosenbloom, M.D., a distinguished service professor emeritus of pediatrics at UF's College of Medicine, to receive its 2003 Distinguished Physician Award for his outstanding contributions to the practice of clinical endocrinology. He will be presented the award, which includes a $3,000 honorarium, next June at the organization's annual meeting in Philadelphia.

This article was featured in the September 10, 2002 issue of the Health Science Center News (by Lisa Vela). For the full version Click here. (Posted 10/04/02)

The following changes have been made to the remaining sessions of the Research Administrators Training Series sessions:

Session 7 Topic: "Research Compliance/Responsible Conduct"
Previously scheduled for October 23, 2002. The date on this session has been changed to: November 20, 2002 - 11:30 am - 1:00 pm Reitz Union, Room
361

Session 8 Topic: "Indirect Cost" - this session has been postponed -
no future date has been assigned
This session was previously scheduled for November 20 but has been replaced by "Research Compliance/ Responsible Conduct" session.

If you have previously registered for the session on "Research
Compliance/Responsible Conduct" session, you are still registered for the new date.

Please feel free to email Linda Taylor or give her call at 392-3516 if you have any questions.
(Posted 10/04/02)

The University of Miami Ethics Programs will host a workshop entitled, "Extreme Ethics: Unusually Difficult Challenges in Epidemiology and Human Subjects Research" on October 24-26, 2002 at the Sheraton Biscayne Bay Hotel in Miami, Florida. The workshop is supported by a grant from the National Institutes of Health.

For more information, go to the brochure on Extreme Ethics. (Posted 10/04/02)

Pharmaceutical Education Associates present "Sucessful Inspections & Audits, Achieving Compliance with FDA Requirements" on November 18-19, 2002 at the Ronald Reagan Building at the International Trade Center in Washington, DC.

For more information and agenda, go to the brochure on Inpections & Aduits. (Posted 10/04/02)

IRB Investigator -IRB-01 Deadline Changes!

Please review the new IRB Deadlines as they have been updated to accommodate administrative changes in the IRB office. The updated Deadlines can be located at the following IRB-01 website: http://rgp.ufl.edu/irb/irb01/. Scroll down to the bottom of the page and note the "New Deadlines In Effect" notice inserted into the deadline table. Reminder: Deadlines relate only to those IRB submissions that require a full Board review: initial and continuing review of full Board studies, tabled items, major revisions, and serious and unexpected adverse events must adhere to the posted deadline schedule.

New forms help the IRB maintain its responsibility to uphold human subjects protections standards and ideals.

This announcement appeared in the September 2002, IRB Investigator. (Reposted 10/04/02)

IRB Investigator -October 1st - New Forms Become Mandatory

Beginning October 1, 2002 the use of "new" IRB-01 forms will become mandatory. All IRB submissions turned into the IRB on or after October 1st must be prepared on the new forms or they will be returned to the Investigator. New forms are currently available at the IRB-01 website: Downloadable Forms. This is a good time to familiarize yourself with these new forms. The IRB Form Forum will take place on September 12th (see registration information below). If you have any questions about the use of the new forms, bring them to the Forum!

The new forms are designed to help the IRB conduct a more thorough and complete review of research. Please direct any problems or questions you may have regarding the new forms to the IRB office.

This announcement appeared in the September 2002, IRB Investigator. (Reposted 10/04/02)

WHAT'S NEW?

RADIOLOGY PROFESSIONAL FEES FOR RESEARCH & CLINICAL TRIAL STUDIES

If your department is involved in putting together a research budget for clinical trials/research studies which involve radiological services, please contact Brenda Wise in Radiology at 265-0680 X44329 or email her at wisebc@radiology.ufl.edu to obtain the correct price for each procedure. If you currently have ongoing clinical trials/research studies involving these services, please contact her in order for her to obtain information regarding your study(ies) for billing purposes. This will preclude your patients from receiving a bill for these services.

Please note that Shands will charge the research study for the technical fee component of the radiological procedure as well. (Posted 10/04/02)

NINDS POLICY UPDATE FOR CAREER (K) AWARDS

This notices outlines additional policies and procedures for each K other then what is outlined on the standard criteria in each of the parent NIH-wide program announcements for K awards. This policy notice replaces the previous notice NOT-NS-02-014 issued on July 8, 2002 (http://grants.nih.gov/grants/guide/notice-files/NOT-NS-02-014.html).

The NINDS supports a broad spectrum of K awards, including both mentored and independent awards. These programs are described in the NINDS training and career development website:
http://www.ninds.nih.gov/funding/research_training.htm.

Salary and Research Costs:

The allowable salary and research costs at NINDS for the K01, K02, K08, K22, K23 career award mechanisms are as follows:

Effective with career awards funded in FY 2002, all competing (Type 1) applications are eligible to request the following salary and research costs (increased over our previous levels):

o Maximum allowable salary is $85,000 per year.
o Maximum allowable research costs is $50,000 per year.
o Maximum allowable total direct costs for the 3-year extramural phase of the K22 awards is $150,000; applicants may request any combination of salary (up to $85,000) and research costs up to the maximum allowable direct costs.

All non-competing (Type 5) K01, K08, and K23 awards will continue to receive salary and research support under the original terms and conditions of the award. However, all non-competing (Type 5) K02 recipients will receive $50,000 for research costs. There will be no change in salary level for non-competing K02 awards.

NOTE: The salary limits and research costs for the following career award mechanisms remain the same. These programs follow separate NIH- wide guidelines:
o Midcareer Investigator Award in Patient-Oriented Research (K24)
o Mentored Quantitative Research Career Development Award (K25)

For an outline of the Overall NINDS Career (K) Programs and a
the full version of this annoucement, go to NOTICE: NOT-NS-03-001.

This announcement appeared in the September 27, 2002, NIH Guide*NOTICE:NOT-NS-03-001 . (Posted 10/04/02)

CLARIFICATION OF THE NCI POLICY ON ACCEPTANCE FOR REVIEW OF UNSOLICITED APPLICATIONS THAT REQUEST $500,000 OR MORE DIRECT COSTS

This notice is a clarification of the National Cancer Institute policy which supplements NIH policy as published March 20, 1998,
http://grants.nih.gov/grants/guide/notice-files/not98-030.html,
and revised October 16, 2001,
http://grants.nih.gov/grants/guide/notice-files/NOT-OD-02-004.html.

The purpose is to emphasize the requirement that applicants who plan to submit applications of $500,000 or larger direct costs must contact the National Cancer Institute Referral Office to seek approval at least 6 weeks before the application is submitted. All grant applications utilizing mechanisms, including but not limited to P01, P30, R01, R21/R33, and U10, where direct costs equal or exceed $500,000 are covered by this notice except for applications in response to a specific Request For Applications and Small Business Innovation Research Grants. This requirement covers new, competing continuations, supplements, and all amended applications. The information is specific for each receipt date and will not be carried over from one round to another. If an applicant is delayed and cannot meet the planned receipt date, a new request will be required for the next receipt date.

For the full version of this annoucement, go to : NOTICE:NOT-CA-02-029

This announcement appeared in the September 27, 2002, NIH Guide*NOTICE:NOT-CA-02-029.(Posted 10/04/02)

UF Internal Deadline Procedure

Certain agencies announce Requests for Applications that limit the number of proposals that can be submitted by the University. In these instances, the Office for Research Affairs will post an internal deadline for interested faculty to submit a Letter of Intent to the Office for Research Affairs.

If there are more applicants interested in submitting a proposal than the agency's guidelines allow for, an internal review process will be coordinated by ORA. ORA will only coordinate the requests that are specifically for health related projects. RGP will coordinate all other requests. There is not always a candidate who applies for an award. If you are interested in a funding opportunity and the internal deadline has passed, check with ORA to see if this opportunity is still available.

Contact Dr. Madsen with questions related to funding opporunities or internal competitions.

Upcoming Internal Deadlines
There are no internal deadlines this week (Posted 10/04/02)

NEW FUNDING
OPPORTUNITIES

The National Science Foundation is accepting applications for the "2003-2004 competition for the NSF Graduate Research Fellowship Program". Applications are due by November 7, 2002. Click here to download brochure and Click here to download application forms.

The American Academy of Allergy Asthma & Immunology is pleased to announce the availability of "AAAAI's Chrysalis Project Travel and Housing grants" to be awarded to selected medical students for attendance at the 2003 60th Anniversary AAAAI Anual Meeting in Dever Colorado. Applications are due by November 8, 2002. For an application, contact ORA at 392-5398.


The National Research Council of the National Academies is accepting applications for the Ford Foundation Fellowships for Minorities. Predoctoral Fellowship Applications are due by November 20, 2002, Dissertation Fellowship Applications are due by December 4, 2002, and Postdoctoral Fellowship Applications are due by January 8, 2003. Click here for the an application.


The McNight Endowment Fund for Neuroscience invites Letters of Intent (LOI) for the "2003 McNight Technological Innovations in Neurosciene Awards". LOI's are due by December 1, 2002.


The Society for Pediatric Research is accepting nominations for the "2003 Young Investigator Award". Nominations are due by December 6, 2002. Click here for an application.

The Drug Information Association is accepting applications for the "Research Grant Program". Applications are due by December 15, 2002. Click here for an application.


The McNight Endowment Fund for Neuroscience is accepting applications for the "2003 McNight Scholar Awards". Applications are due by January 2, 2003. Click here to download an application forms and guidelines.


The American Heart Association-FL/Puerto Rico Affiliate is accepting applications for 2003 Research Awards. Applications are due by January 13, 2003. Click here for instructions on electronic submission.


The Bristol-Myers Squibb Company is accepting nominations for the Distinguished Achievement in Neuroscience Research. Applications are due by January 23, 2003. Click here to download an application forms.

For funding opportunities annouced by Research and Graduate Programs FYI http://rgp.ufl.edu/fyi/


New NIH notices, requests for applications and program announcements can be found at NIH Notice

ORA News Online is a weekly publication of the College of Medicine Office for Research Affairs in the Health Science Center at the University of Florida, JHMHSC M134, PO Box 100215, Gainesville, FL 32611-0215. Please send any comments or suggestions about this newsletter to Aundrea Corbit “SUGGESTIONS”.  If you do not want to receive any more issues, please reply to Aundrea Corbit with "UNSUBSCRIBE" in the subject line or body of the email.